...
机译:一种新的方法,以在采用免疫疗法后同时量化TCRα-和β-链多样性
Department of Melanoma Medical Oncology University of Texas MD Anderson Cancer Center 1515;
Division of Pediatrics University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. Houston;
Department of Melanoma Medical Oncology University of Texas MD Anderson Cancer Center 1515;
Division of Pediatrics University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. Houston;
Division of Pediatrics University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. Houston;
Stem Cell Transplantation and Cellular Therapy University of Texas MD Anderson Cancer Center;
Department of Melanoma Medical Oncology University of Texas MD Anderson Cancer Center 1515;
Department of Melanoma Medical Oncology University of Texas MD Anderson Cancer Center 1515;
Department of Melanoma Medical Oncology University of Texas MD Anderson Cancer Center 1515;
Division of Pediatrics University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd. Houston;
机译:一种新的方法,以在采用免疫疗法后同时量化TCRα-和β-链多样性
机译:S78。提交的文章:适用于过继免疫疗法的高亲和力CD20特异性TCR可以使用逆向免疫学轻易地从同种异体库中分离出来
机译:S78。提交的文章:适用于过继免疫疗法的高亲和力CD20特异性TCR可以使用逆向免疫学轻易地从同种异体库中分离出来
机译:适应性T细胞免疫治疗的设施设计概念
机译:靶向前列腺中表达的自身/肿瘤抗原,用于前列腺癌的过继T细胞免疫疗法。
机译:一种新的方法以在采用免疫疗法后同时量化TCRα-和β-链多样性
机译:一种新的方法,以在采用免疫疗法后同时量化TCRα-和β-链多样性
机译:上皮性卵巢癌的过继免疫治疗使用T细胞同时针对肿瘤和肿瘤相关的巨噬细胞。